Emergent BioSolutions Announces 2022 Financial Guidance,
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45...
Stay updated with breaking news from Robertg Kramer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Expects a re-baseline of operations with stable revenue contributions from core products and services business in 2022, guiding to total revenues of $1.45...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Jacquelyn Kung, DrPH, MBA A recent Ziegler study found that 70% of long-term care organizations likely would have CEOs retiring in the next five years.
EBS earnings call for the period ending October 3, 2021.
•Reaffirms 2021 Full Year Forecast for Revenues and Profit GAITHERSBURG, Md., July 29, 2021-Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2021. 'Our second quarter performance demonstrates the strength of our strategy and diversified business model,' said Robert G. Kramer, president and chief executive officer of Emergent BioSolutions. 'Through continued investment and innovation, we will play an important role in helping deliver solutions to the public health threats we face. We are proud to be resuming produ...